Arcadia Biosciences Inc (RKDA)

Currency in USD
1.090
-0.030(-2.68%)
Closed·
1.130+0.040(+3.67%)
·
RKDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.0901.140
52 wk Range
0.8906.710
Key Statistics
Prev. Close
1.12
Open
1.14
Day's Range
1.09-1.14
52 wk Range
0.89-6.71
Volume
15.68K
Average Volume (3m)
34.76K
1-Year Change
-63.0363%
Book Value / Share
3.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RKDA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.000
Upside
+1,000.92%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Arcadia Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Arcadia Biosciences Inc Earnings Call Summary for Q1/2025

  • Q1 2025 revenue up 22% to $1.2M, driven by 90% growth in Zola coconut water sales; gross margin steady at 43%
  • Cash position decreased to $3.2M; $1M in non-current liabilities eliminated; $750K gain from patent sale
  • Anticipates future growth from Zola line; expects gross margins to trend toward low 30% range
  • Business combination with Roosevelt Resources expected by August 15; minimal impact from new tariffs anticipated
  • Expansion pipeline of 3,500 stores; new distribution wins to influence 2025 financials; remaining tomato patent has potential value
Last Updated: 2025-05-08, 02:32 p/m
Read Full Transcript

Compare RKDA to Peers and Sector

Metrics to compare
RKDA
Peers
Sector
Relationship
P/E Ratio
−1.0x9.7x12.1x
PEG Ratio
−0.010.110.03
Price/Book
0.5x3.3x1.5x
Price / LTM Sales
0.5x1.7x0.9x
Upside (Analyst Target)
-45.7%21.7%
Fair Value Upside
Unlock3.1%11.0%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.000
(+1,000.92% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 26, 2026
EPS / Forecast
-0.98 / -0.99
Revenue / Forecast
901K / --
EPS Revisions
Last 90 days

RKDA Income Statement

People Also Watch

0.629
BKYI
0.00%
0.539
GFAI
+3.45%
0.835
USEG
+1.58%
0.2140
MGN
+1.90%

FAQ

What Is the Arcadia Biosciences (RKDA) Stock Price Today?

The Arcadia Biosciences stock price today is 1.090 USD.

What Stock Exchange Does Arcadia Biosciences Trade On?

Arcadia Biosciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Arcadia Biosciences?

The stock symbol for Arcadia Biosciences is "RKDA."

What Is the Arcadia Biosciences Market Cap?

As of today, Arcadia Biosciences market cap is 2.270M USD.

What Is Arcadia Biosciences's Earnings Per Share (TTM)?

The Arcadia Biosciences EPS (TTM) is -1.710.

From a Technical Analysis Perspective, Is RKDA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Arcadia Biosciences Stock Split?

Arcadia Biosciences has split 2 times.

How Many Employees Does Arcadia Biosciences Have?

Arcadia Biosciences has 8 employees.

What is the current trading status of Arcadia Biosciences (RKDA)?

As of Apr 23, 2026, Arcadia Biosciences (RKDA) is trading at a price of 1.090 USD, with a previous close of 1.120 USD. The stock has fluctuated within a day range of 1.090 USD to 1.140 USD, while its 52-week range spans from 0.890 USD to 6.710 USD.

What Is Arcadia Biosciences (RKDA) Price Target According to Analysts?

The average 12-month price target for Arcadia Biosciences is 12.000 USD, with a high estimate of 12 USD and a low estimate of 12 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,000.92% Upside potential.

What Is the RKDA Premarket Price?

RKDA's last pre-market stock price is 1.170 USD. The pre-market share volume is 760.000, and the stock has decreased by 0.050, or 4.460%.

What Is the RKDA After Hours Price?

RKDA's last after hours stock price is 1.130 USD, the stock has decreased by 0.040, or 3.670%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.